NYSE:PEN - Penumbra Stock Price, Forecast & News

Penumbra trades on the New York Stock Exchange (NYSE) under the ticker symbol "PEN."

Penumbra Inc (NYSE:PEN) announced its earnings results on Thursday, November, 7th. The company reported $0.25 EPS for the quarter, topping the consensus estimate of $0.18 by $0.07. The company had revenue of $139.50 million for the quarter, compared to analysts' expectations of $133.98 million. Penumbra had a return on equity of 7.23% and a net margin of 8.69%. The business's revenue for the quarter was up 24.8% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.17 earnings per share. View Penumbra's Earnings History.

Penumbra is scheduled to release their next quarterly earnings announcement on Tuesday, February 25th 2020. View Earnings Estimates for Penumbra.

7 Wall Street analysts have issued 1-year price objectives for Penumbra's stock. Their forecasts range from $180.00 to $200.00. On average, they anticipate Penumbra's stock price to reach $191.40 in the next year. This suggests a possible upside of 12.2% from the stock's current price. View Analyst Price Targets for Penumbra.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Penumbra in the last year. There are currently 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Penumbra.

News stories about PEN stock have been trending somewhat negative on Thursday, InfoTrie reports. The research firm ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Penumbra earned a media sentiment score of -1.6 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Penumbra.

Some companies that are related to Penumbra include ResMed (RMD), DexCom (DXCM), Teleflex (TFX), Insulet (PODD), Novocure (NVCR), ABIOMED (ABMD), Hill-Rom (HRC), Haemonetics (HAE), Globus Medical (GMED), Integra Lifesciences (IART), Tandem Diabetes Care (TNDM), NuVasive (NUVA), ICU Medical (ICUI), Nevro (NVRO) and Cantel Medical (CMD).

Based on aggregate information from My MarketBeat watchlists, some companies that other Penumbra investors own include Netflix (NFLX), NVIDIA (NVDA), Alibaba Group (BABA), Splunk (SPLK), Intuitive Surgical (ISRG), salesforce.com (CRM), Paypal (PYPL), AbbVie (ABBV), Twilio (TWLO) and Adobe (ADBE).

Penumbra's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Louisiana State Employees Retirement System (0.02%), Leavell Investment Management Inc. (0.02%), Mission Wealth Management LP (0.02%), Campbell & CO Investment Adviser LLC (0.02%), State of Alaska Department of Revenue (0.02%) and Alpine Global Management LLC (0.01%). Company insiders that own Penumbra stock include Adam Elsesser, Arani Bose, Bridget O'rourke, Coyne David, Daniel Donen Davis, Don W Kassing, Harpreet Grewal, James Robert Pray, Johanna Roberts, Lynn Rothman, Robert D Evans, Sridhar Kosaraju and Thomas Wilder. View Institutional Ownership Trends for Penumbra.

PEN stock was sold by a variety of institutional investors in the last quarter, including Mission Wealth Management LP, State of Alaska Department of Revenue, CENTRAL TRUST Co and Leavell Investment Management Inc.. Company insiders that have sold Penumbra company stock in the last year include Adam Elsesser, Arani Bose, Bridget O'rourke, Don W Kassing, Harpreet Grewal, James Robert Pray, Lynn Rothman, Sridhar Kosaraju and Thomas Wilder. View Insider Buying and Selling for Penumbra.

PEN stock was acquired by a variety of institutional investors in the last quarter, including Alpine Global Management LLC, Sciencast Management LP, Campbell & CO Investment Adviser LLC, Advisors Capital Management LLC, Exchange Traded Concepts LLC and Louisiana State Employees Retirement System. View Insider Buying and Selling for Penumbra.

Shares of PEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of PEN stock can currently be purchased for approximately $170.59.

Penumbra has a market capitalization of $5.96 billion and generates $444.94 million in revenue each year. The company earns $6.60 million in net income (profit) each year or $0.51 on an earnings per share basis. Penumbra employs 2,200 workers across the globe.View Additional Information About Penumbra.

The official website for Penumbra is http://www.penumbrainc.com/.

Penumbra's mailing address is One Penumbra Place, Alameda CA, 94502. The company can be reached via phone at 510-748-3200 or via email at [email protected]